Merck
Stay current with all the latest and breaking news about Merck, compare headlines and perspectives between news sources on stories happening today. In total, 107 stories have been published about Merck which Ground News has aggregated in the past 3 months.Stay current with all the latest and breaking news about Merck, compare headlines and perspectives between news sources on stories happening today. In total, 107 stories have been published about Merck which Ground News has aggregated in the past 3 months.
Local News Publishers
No sources with tracked biases.
See less detail
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Merck News
Latest News Stories
US & CanadaPharmaceutical company Merck said that it is working to reduce levels of a cancer-causing organic compound that was found in some of its popular type 2 diabetes drugs.
Pharma company says it's working to reduce levels of cancer-causing compound in popular diabetes drugs
96% Center coverage: 24 sources
Google · New YorkProfessor Emeritus of Epidemiology at the Yale School of Public Health, Dr. Harvey Risch, says that if Pfizer mutated the virus and released it into circulation, it would be domestic terrorism.
Epidemiologist says if Pfizer mutated COVID-19 and released it into circulation it would be a crime
100% Right coverage: 8 sources
MerckLagevrio, the FDA-authorized oral COVID-19 therapy, leads to new mutations in the virus, according to a new study. The researchers in the U.S. and U.K. collaborated with those in the Francis Crick Institute, Imperial College, and the University of Liverpool.
Merck COVID-19 pill linked to virus mutations – study (NYSE:MRK)
67% Center coverage: 3 sources
AnimalsMerck's COVID-19 pill was not effective at cutting the risk of coronavirus infections in people living with someone infected with the virus. Results were similar to data from rival Pfizer Inc (PFE.N), whose COVID pill Paxlovid also failed to prevent infections among household contacts.
Merck's COVID pill fails to prevent infection among household members
67% Center coverage: 3 sources
EuropeModerna and Merck's personalized mRNA cancer vaccine mRNA-4157/V940, in combination with Keytruda, for the adjuvant treatment of patients with high-risk melanoma after complete resection. FDA's decision was backed by data from a phase 2b trial, dubbed KEYNOTE-942/mRNA- 4157-P201.
Moderna, Merck's mRNA cancer vaccine, Keytruda combo gets FDA breakthrough therapy tag
67% Center coverage: 3 sources
MerckMerck’s KEYTRUDA Plus Chemotherapy Met Primary Endpoint of PFS as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma
FDAPfizer's Paxlovid and Merck's Lagevrio pills were given emergency use authorizations in Dec. 2021. FDA said the patients should have a current diagnosis of mild-to-moderate COVID infection. Individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID even if they have a negative test result.
U.S. FDA removes COVID test requirements for Pfizer, Merck pills
Coverage: 2 sources
CancerMerck & Co (MRK.N) has discovered how its blockbuster diabetes drugs have become contaminated with a potential carcinogen. The impurity arose mostly during storage, as well as during manufacturing, Bloomberg News said. The company submitted a report to the U.S. Food and Drug Administration.
Merck set to remove cancer-causing chemical from top diabetes drugs
Coverage: 2 sources
